Moderna
MRNA
#1360
Rank
NZ$23.24 B
Marketcap
$60.41
Share price
-6.51%
Change (1 day)
-61.64%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$23.24 Billion

As of February 2025 Moderna has a market cap of NZ$23.24 Billion. This makes Moderna the world's 1360th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$23.24 B-15.11%
2024NZ$27.38 B-54.33%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On Feb 4th, 2025 the market cap of Moderna was reported to be:

NZ$23.24 Billion
by Yahoo Finance info icon info icon
NZ$23.24 Billion
by CompaniesMarketCap info icon info icon
NZ$23.24 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$0.15 B-99.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$405.77 B 1,645.65%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.47 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$61.79 B 165.82%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$368.25 B 1,484.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$4.35 B-81.28%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$653.28 B 2,710.40%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.26 B-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA